ABMD — Abiomed Balance Sheet
0.000.00%
Last trade - 00:00HealthcareAdventurousLarge Cap
- $17.18bn
- $16.36bn
- $1.03bn
Annual balance sheet for Abiomed, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 362 | 492 | 443 | 584 | 759 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 70 | 90.8 | 84.7 | 97.2 | 90.6 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 494 | 677 | 636 | 788 | 976 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 117 | 145 | 177 | 203 | 212 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 786 | 1,054 | 1,216 | 1,494 | 1,673 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 84.7 | 106 | 132 | 129 | 138 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 96.9 | 117 | 151 | 165 | 170 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 690 | 937 | 1,065 | 1,330 | 1,503 |
| Total Liabilities & Shareholders' Equity | 786 | 1,054 | 1,216 | 1,494 | 1,673 |
| Total Common Shares Outstanding |